Ausgabe 10/2018
Inhalt (20 Artikel)
Safety and tolerability of PD-1/PD-L1 inhibitors in the treatment of non-small cell lung cancer: a meta-analysis of randomized controlled trials
Wenxin Luo, Zhoufeng Wang, Panwen Tian, Weimin Li
An insight into the molecular genetics of a uveal melanoma patient cohort
Susan Kennedy, Michael Rice, Sinead Toomey, Noel Horgan, Bryan T. Hennessey, Annemarie Larkin
Distinct subgroup of the Ras family member 3 (DIRAS3) expression impairs metastasis and induces autophagy of gastric cancer cells in mice
Jingping Qiu, Xiaoting Li, Yingjian He, Dan Sun, Wenhui Li, Yan Xin
Expression of phosphorylated estrogen receptor beta is an independent negative prognostic factor for pancreatic ductal adenocarcinoma
Ioannis Pozios, Thomas Knösel, Yue Zhao, Gerald Assmann, Iraklis Pozios, Mario H. Müller, Christiane J. Bruns, Martin E. Kreis, Hendrik Seeliger
TA-MUC1 as detected by the fully humanized, therapeutic antibody Gatipotzumab predicts poor prognosis in cervical cancer
Sabine Heublein, Klaus Friese, Bernd Kost, Frederik Marmé, Christina Kuhn, Sven Mahner, Christian Dannecker, Doris Mayr, Udo Jeschke, Aurelia Vattai
PD-1 blockade enhances radio-immunotherapy efficacy in murine tumor models
Yuan Zhuang, Sihan Li, Huihui Wang, Jingbo Pi, Yuhui Xing, Guang Li
Somatostatin and CXCR4 expression patterns in adenocarcinoma and squamous cell carcinoma of the lung relative to small cell lung cancer
Claudia Stumpf, Daniel Kaemmerer, Elisa Neubauer, Jörg Sänger, Stefan Schulz, Amelie Lupp
Diverging impact of cell fate determinants Scrib and Llgl1 on adhesion and migration of hematopoietic stem cells
Banaja P. Dash, Tina M. Schnöder, Carolin Kathner, Juliane Mohr, Sönke Weinert, Carolin Herzog, Parimala Sonika Godavarthy, Costanza Zanetti, Florian Perner, Rüdiger Braun-Dullaeus, Björn Hartleben, Tobias B. Huber, Gerd Walz, Michael Naumann, Sarah Ellis, Valera Vasioukhin, Thilo Kähne, Daniela S. Krause, Florian H. Heidel
Protective immunity elicited by measles vaccine exerts anti-tumor effects on measles virus hemagglutinin gene-modified cancer cells in a mouse model
Yuan Qi, Kailin Xing, Lanlin Zhang, Fangyu Zhao, Ming Yao, Aiqun Hu, Xianghua Wu
Non-participation in breast cancer screening among previous cancer patients
Line Flytkjær Virgilsen, Anette Fischer Pedersen, Berit Andersen, Peter Vedsted
The clinical usefulness of optical coherence tomography during cancer interventions
Labrinus van Manen, Jouke Dijkstra, Claude Boccara, Emilie Benoit, Alexander L. Vahrmeijer, Michalina J. Gora, J. Sven D. Mieog
Quality of life in patients undergoing repetitive TACE for the treatment of intermediate stage HCC
K. J. Hartrumpf, S. Marquardt, T. Werncke, T. Murray, M. M. Kirstein, A. Vogel, F. Wacker, T. Rodt
Clinical validation of the next-generation sequencing-based Extended RAS Panel assay using metastatic colorectal cancer patient samples from the phase 3 PRIME study
Nitin Udar, Catherine Lofton-Day, Jun Dong, Darcy Vavrek, A. Scott Jung, Kristen Meier, Anita Iyer, Ryan Slaughter, Karen Gutekunst, Bruce A. Bach, Marc Peeters, Jean-Yves Douillard
Endometrial cancer subtypes are associated with different patterns of recurrence
Tanja Ignatov, Holm Eggemann, Serban Dan Costa, Olaf Ortmann, Atanas Ignatov
Is there a benefit of lymphadenectomy for overall and recurrence-free survival in type I FIGO IB G1-2 endometrial carcinoma? A retrospective population-based cohort analysis
Thomas Papathemelis, Dunja Hassas, Michael Gerken, Monika Klinkhammer-Schalke, Anton Scharl, Michael P. Lux, Mathias W. Beckmann, Sophia Scharl
Use and perception of complementary and alternative medicine among cancer patients: the CAMEO-PRO study
Claudia Bozza, Lorenzo Gerratana, Debora Basile, Maria Grazia Vitale, Michele Bartoletti, Elisa Agostinetto, Stefania Russo, Alessandro Follador, Elisa De Carlo, Nicoletta Pella, Roberta Sottile, Gianpiero Fasola, Fabio Puglisi
Expressional profiling and clinical relevance of RNase κ in prostate cancer: a novel indicator of favorable progression-free survival
Athina Kladi-Skandali, Konstantinos Mavridis, Andreas Scorilas, Diamantis C. Sideris
Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice
Martin Faehling, Birgit Schwenk, Sebastian Kramberg, Sabine Fallscheer, Matthias Leschke, Jörn Sträter, Robert Eckert
Evaluation of Vav3.1 as prognostic marker in endometrial cancer
Maximilian Boesch, Sieghart Sopper, Christian Marth, Heidi Fiegl, Annemarie Wiedemair, Julia Rössler, Jiri Hatina, Dominik Wolf, Daniel Reimer, Alain G. Zeimet
Stereotactic body radiation therapy for centrally located hepatocellular carcinoma: outcomes and toxicities
Stanislav Lazarev, Camille Hardy-Abeloos, Oren Factor, Kenneth Rosenzweig, Michael Buckstein